In January 2025, Elicio reached alignment with regulatory authorities on a registrational strategy for ELI-002 in post-resection (adjuvant setting) mKRAS PDAC. Specifically, Elicio aligned with the ...

This article explores ten groundbreaking contributions AI has made to society, highlighting how AI is influencing our ...

Discover how understanding and supporting your body’s natural balance of homeostasis can boost mood, resilience, and overall ...

Research and development expenses were $6.7 million for the first quarter ended March 31, 2025, compared to $10.4 million in ...

Retail chatter around Moleculin Biotech surged on Monday after the company said the European Medicines Agency had approved ...

Emma Sullivan summarises a cross-sectional observational study investigating associations between school smartphone policies ...

The HIV Clinical Trials Market focuses on the systematic evaluation of novel antiretroviral therapies, combination regimens, long-acting injectables, and immunotherapeutic approaches to control and ...

Adds nine additional countries to the Company's ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested Enrollment and dosing underway in Phase 3 clinical trial (the "MIRACL ...

Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries ...

This study provides a valuable extension of credibility-based learning research by showing how feedback reliability can distort reward-learning biases in a disinformation-like bandit task. Although ...

Q1 2025 Results Conference Call May 6, 2025 4:30 PM ETCompany ParticipantsBlake Beber - Head, IRSean Saint - President ...

Q1 2025 Earnings Call Transcript May 9, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations ...